Category: Misc. Research Reports

Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™

May 4, 2012 TAMPA, Fla.–(BUSINESS WIRE)–Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI) today announced that the Company and leading physicians from Johns Hopkins…

Stuart Schlossman

Full CARE-MS II Results for Alemtuzumab to Be Unveiled

PRESS RELEASE April 20, 2012, 1:00 a.m. EDT Genzyme Demonstrates Depth of MS Pipeline at AAN with Results from Multiple…

Stuart Schlossman

Opexa to Hold Preliminary Investigator’s Meeting for MS Trial at American Academy of Neurology Annual Meeting

THE WOODLANDS, Texas–(BUSINESS WIRE)–Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis…

Stuart Schlossman

Bridge the Gap Between Basic Research and Patient Care, NIH Head Urges

Information provided by Mitchell A., in California By Shirley S. Wang Associated Press Francis Collins, head of the National Institutes…

Stuart Schlossman

Univ of Rochester neurologist scores national MS fellowship

Jessica Robb, after nearly four years of a neurology residency at Strong Memorial Hospital, is going nowhere soon. The National…

Stuart Schlossman

Once Hopeful Teriflunomide, Failed expectations

France’s Sanofi said its multiple sclerosis drug candidate teriflunomide did not achieve one of its goals in a late-stage clinical…

Stuart Schlossman

Vitamin D warning: Too much can harm your heart

By Linda Carroll – msnbc.com contributor –  Nov 16, 2011 When it comes to the heart, vitamin D can be a double-edged…

Stuart Schlossman

The myelination process is an essential part of brain development.

Information was provided to me from Nina Faith in Florida… Wed- August 10, 2011 Brain electrical activity spurs insulation of…

Stuart Schlossman

Israel’s Weizmann Institute of Science leads in research and discovery

Washington, July 29, 2011-At the dawn of life, as babies are born, they enter a welcoming world filled with surprises…

Stuart Schlossman

The NYSCF scientific team is leveraging recent advances in stem cell research to study multiple sclerosis through the creation of disease-specific stem cell lines

NYSCF-Helmsley Investigator Valentina Fossati speaking at the 2010 Druckenmiller Fellows Reception  For patients with MS, the cells of the immune system attack…

Stuart Schlossman

Categories

Latest Blog Posts